Professional
Added to YB: 2024-10-23
Pitch date: 2024-09-30
BAYN.DE [bullish]
Bayer Aktiengesellschaft
+30.56%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Market Cap
EUR 36.9B
Pitch Price
EUR 30.40
Price Target
N/A
Dividend
0.29%
EV/EBITDA
7.31
P/E
-10.20
EV/Sales
1.47
Sector
Pharmaceuticals
Category
special_situation
Show full summary:
Oakmark Global Strategy Portfolio Holding: Bayer Aktiengesellschaft
BAYN.DE: Stock up on favorable US RoundUp ruling. CFO update on DSO reorganization: 900+ teams, streamlining ops. Focus on cost & execution. Long-term shareholder benefit potential. Pharma, consumer health & crop science company.
Read full article (1 min)